Before starting statin therapy, what lab test should be checked due to potential hepatotoxicity?

Prepare for the NCLEX exam effectively with our NCLEX Uworld Practice Test. Use flashcards and multiple choice questions with detailed hints and explanations to ensure you're ready for success!

Multiple Choice

Before starting statin therapy, what lab test should be checked due to potential hepatotoxicity?

Explanation:
Checking liver function tests before starting a statin targets the risk of hepatotoxicity by establishing a baseline hepatic status. Statins can cause elevations in liver enzymes, so having baseline ALT/AST and overall LFTs allows clinicians to detect preexisting liver disease and to monitor for any drug-induced injury once therapy begins. If the baseline is normal, treatment can proceed with periodic rechecks to catch any early elevations; if abnormal, the clinician may reconsider statin use or choose a different therapy and monitor closely. Urinalysis, renal function tests, and CBC assess other organ systems or conditions and don’t specifically monitor for statin-related liver injury, though they are useful in broader patient assessment.

Checking liver function tests before starting a statin targets the risk of hepatotoxicity by establishing a baseline hepatic status. Statins can cause elevations in liver enzymes, so having baseline ALT/AST and overall LFTs allows clinicians to detect preexisting liver disease and to monitor for any drug-induced injury once therapy begins. If the baseline is normal, treatment can proceed with periodic rechecks to catch any early elevations; if abnormal, the clinician may reconsider statin use or choose a different therapy and monitor closely. Urinalysis, renal function tests, and CBC assess other organ systems or conditions and don’t specifically monitor for statin-related liver injury, though they are useful in broader patient assessment.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy